» Articles » PMID: 37389590

Incidence and Prevalence of Spinal and Bulbar Muscular Atrophy in South Korea: a Nationwide Population-based Study

Overview
Journal J Neurol
Specialty Neurology
Date 2023 Jun 30
PMID 37389590
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal and bulbar muscular atrophy (SBMA), or Kennedy's disease, is a rare X-linked neuromuscular disorder predominantly affecting males and caused by a mutation in the androgen receptor gene. The epidemiology and comorbidities associated with SBMA in different ethnicities remain poorly understood. This study investigated the prevalence, incidence, and comorbidities associated with SBMA in the South Korean population using the Health Insurance Review and Assessment Service (HIRA) database. We retrospectively reviewed diagnosed cases of SBMA (G12.25 code of the Korean Classification of Diseases-7th edition) registered from January 1, 2016, to December 31, 2019, to calculate incidence and prevalence rates and concomitant comorbidities. Additionally, we surveyed SBMA patients (questionnaire group) visiting our clinic in 2022 to compare comorbidities with the HIRA data. The mean incidence rate of SBMA in the Korean population was 0.36/100,000 males from 2018 to 2019, while the prevalence rate was approximately 0.46/100,000 males from 2016 to 2019. The most common comorbidities identified in HIRA were gastritis and duodenitis (99.7%), gastroesophageal reflux (90.5%), hyperlipidemia (88.4%), and liver disorders (75.2%), which showed similar results in the questionnaire group. Additionally, gastric cancer was the most common type of cancer reported in SBMA in South Korea; although indeterminate, age-related factors may contribute to the development of cancer in these patients. Our findings provide valuable insights into the epidemiology and associated comorbidities of SBMA within the Korean population, which could inform clinical practice and future clinical research.

Citing Articles

Association of serum Spp1 levels with disease progression in ALS and SBMA.

Ju W, Ban J, Im H, Ko S, Seo J, Min Y Ann Clin Transl Neurol. 2024; 11(7):1809-1818.

PMID: 38775192 PMC: 11251464. DOI: 10.1002/acn3.52087.

References
1.
La Spada A, Wilson E, Lubahn D, Harding A, Fischbeck K . Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991; 352(6330):77-9. DOI: 10.1038/352077a0. View

2.
Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M . Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain. 2006; 129(Pt 6):1446-55. DOI: 10.1093/brain/awl096. View

3.
Arnold F, Merry D . Molecular Mechanisms and Therapeutics for SBMA/Kennedy's Disease. Neurotherapeutics. 2019; 16(4):928-947. PMC: 6985201. DOI: 10.1007/s13311-019-00790-9. View

4.
Dejager S, Bry-Gauillard H, Bruckert E, Eymard B, Salachas F, Leguern E . A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab. 2002; 87(8):3893-901. DOI: 10.1210/jcem.87.8.8780. View

5.
Fratta P, Nirmalananthan N, Masset L, Skorupinska I, Collins T, Cortese A . Correlation of clinical and molecular features in spinal bulbar muscular atrophy. Neurology. 2014; 82(23):2077-84. PMC: 4075620. DOI: 10.1212/WNL.0000000000000507. View